Mollie Jurewicz
Director, TCR & Autoimmune Discovery TScan Therapeutics
Seminars
Wednesday 20th May 2026
Expanding Therapeutic Possibilities Pursuing pMHC Targets Beyond Convention
11:00 am
- Antigen-guided TCE development
- Targeting haptenated peptides as a way of breaking HLA restriction
- Exploiting resistance mechanisms to cancer treatments that unlock new targets for immunotherapies
